Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
1999 Standout
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Parenteral Anticoagulants
2008
Parenteral Anticoagulants
2012 Standout
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
2009
Heparin-induced thrombocytopenia
1996
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Costs and Effectiveness of Routine Therapy with Long-Term Beta-Adrenergic Antagonists after Acute Myocardial Infarction
1988
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Cardiovascular drug class specificity: β-blockers
2004
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
2004
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2008 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Transfusion Medicine — Blood Transfusion
1999 Standout
α1-acid glycoprotein (AGP)-induced platelet shape change involves the Rho/Rho kinase signalling pathway
2009
Anesthesiology
1997 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component
2009
Heparin and Low-Molecular-Weight Heparin
2004
Heparin-Induced Thrombocytopenia
2006 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Heparin
1991
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamine
1995
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
Heparin‐induced thrombocytopenia: A prospective study
1984
Thrombocytopenia Found Uncommonly During Heparin Therapy
1979
Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets
2011 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits
1982
Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis
1973
Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
1994
A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.
2009
Evaluating the federal role in financing health-related research
1996 StandoutNobel
Heparin-lnduced Thrombocytopenia, Thrombosis, and Hemorrhage
1983
Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
1996
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials
1986
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Effect of very early intervention with metoprolol on myocardial infarct size.
1983
Effect of Heparin and Heparin Fractions on Platelet Aggregation
1980
Thrombocytopenia Occurring During the Administration of Heparin
1976
Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors.
1989 StandoutNobel
Impairment by Heparin of Primary Haemostasis and Platelet [14C]5‐Hydroxytryptamine Release
1977
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Blood pressure, stroke, and coronary heart disease
1990 Standout
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Mechanisms of Diabetic Complications
2013 Standout
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Modulation of adenylate cyclase activity by sulfated glycosaminoglycans II. Effects of mucopolysaccharides and dextran sulfate on the activity of adenylate cyclase derived from various tissues
1978
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
1983
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Low-Molecular-Weight Heparins
1997 Standout
CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION
1982
Thrombocytopenia in a Prospective, Randomized, Double-Blind Trial of Bovine and Porcine Heparin
1984
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
Prognostic Factors in Acute Pulmonary Edema
1986
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
1986
Heparin-Associated Thrombocytopenia
1984
Multiple Myeloma
2011 Standout
A Long-Term Prevention Study with Oxprenolol in Coronary Heart Disease
1982
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Fluorescence-Based Blood Coagulation Assay Device for Measuring Activated Partial Thromboplastin Time
2010 StandoutNobel
Large-Scale Characterization and Analysis of the Murine Cardiac Proteome
2009
EFFECTIVENESS OF LOW-DOSE HEPARIN IN PREVENTION OF MYOCARDIAL REINFARCTION
1987
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia
2001 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Heparin-Associated Thrombocytopenia: A Prospective Comparison of Bovine Lung Heparin, Manufactured by a New Process, and Porcine Intestinal Heparin
1986
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of C. Eika being referenced
Inhibition of Thrombin Induced Aggregation of Human Platelets by Heparin
1971
Incidence and follow‐up of asymptomatic multiple myeloma.
1991
The Value of Preoperative Haemostatic Screening
1978
Platelet Refractory State Induced by Heparin
1972
Anticoagulant and platelet aggregating activities of heparin
1973
THROMBOCYTES AND TREATMENT WITH HEPARIN FROM PORCINE MUCOSA
1980
Low Incidence of Thrombocytopenia during Treatment with Hog Mucosa and Beef Lung Heparin
1981
The Platelet Aggregating Effect of Eight Commercial Heparins
1972
DETECTION OF SMALL AMOUNTS OF HEPARIN BY THE THROMBIN CLOTTING-TIME
1972
On the Mechanism of Platelet Aggregation Induced by Heparin, Protamine and Polybrene
1972
Inhibition of Thrombin‐Induced Platelet Aggregation by Crude and Highly Purified α1‐Acid Glycoprotein
1981
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
1982